Anti-Human CD227 Recombinant Antibody(Clivatuzumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD227 Recombinant Antibody(Clivatuzumab)

Anti-Human CD227 Recombinant Antibody(Clivatuzumab)

产品编号

YR1379

别名

科研级 Clivatuzumab(克利妥珠单抗 ), Anti-CD227 Recombinant Antibody, Research Grade Clivatuzumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Clivatuzumab(克利妥珠单抗 ), Anti-CD227 Recombinant Antibody, Research Grade Clivatuzumab
Catalog Number	YR1379
Molecular Name	Clivatuzumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody-drug conjugate designed for the treatment of pancreatic cancer. The antibody part, clivatuzumab (targeted at MUC1), is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
CAS Number	1462876-11-4
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD227[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0